Welcome to our dedicated page for Amer Shared Hosp news (Ticker: AMS), a resource for investors and traders seeking the latest updates and insights on Amer Shared Hosp stock.
American Shared Hospital Services (NYSE American: AMS) regularly issues news updates that describe its role as a provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services. Its press releases highlight developments across its medical equipment leasing and direct patient care services segments, giving investors and observers insight into how the company’s cancer treatment–focused operations are evolving.
News items frequently cover quarterly and annual financial results, where the company reports revenue from Gamma Knife, linear accelerator (LINAC), and proton beam radiation therapy, as well as performance in its direct patient care services segment. These releases often include management commentary on treatment volumes, contract activity, new center openings, and the balance between leasing and direct patient care services.
American Shared Hospital Services’ news flow also emphasizes business expansion and partnerships. Recent disclosures reference acquiring majority interests in radiation therapy treatment centers in Rhode Island, opening a radiation therapy center in Puebla, Mexico, and planning additional radiation therapy and proton beam centers under Certificate of Need approvals. The company’s descriptions of turnkey solutions for cancer treatment centers, health systems, and cancer networks in North and South America are a recurring theme in its announcements.
Regulatory and corporate governance updates appear in the form of conference call announcements, shareholder meeting notices, and SEC-related disclosures. These include scheduling of earnings calls, participation in investor conferences, and information about annual shareholder meetings. Together, the AMS news feed on this page provides a centralized view of the company’s reported financial performance, operational changes in its cancer treatment services, and key corporate events.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
American Shared Hospital Services (AMS) announced its Annual Meeting of Shareholders will take place on June 20, 2023, at 9:00 a.m. PT, both virtually and in-person at the Hilton Hotel in San Francisco, CA. The record date for determining eligible shareholders is set for April 24, 2023. AMS is a prominent provider of technology solutions for stereotactic radiosurgery and advanced radiation therapy, focusing on cancer treatment facilities. The company collaborates with major OEMs to offer advanced medical equipment, including MR Guided Radiation Therapy Linacs and Proton Beam Therapy Systems. AMS highlights its Gamma Knife radiosurgery equipment for non-invasive tumor treatment. The firm also issued a safe harbor statement discussing potential risks affecting its financial outlook.
American Shared Hospital Services (AMS) reported a strong financial performance for Q4 2022, with revenue exceeding $5 million for the second time in the year, marking a 7.4% increase from Q4 2021. Net income rose by 12% to $246,000 or $0.04 per share. Full-year revenue reached nearly $20 million, representing a 12% increase, while net income surged six-fold to $1.3 million or $0.21 per share. Major highlights include a 33.4% increase in proton therapy revenue, a solid cash position of $12.5 million, and a first order of 2023 valued at $1.3 million. The company is also advancing its joint ventures in Mexico and Ecuador.
American Shared Hospital Services (AMS) announced a quarterly conference call scheduled for March 24, 2023, at 1:00 PM ET to discuss its fourth quarter and year-end 2022 financial results. The financial results press release will be available before market opening on the same date. Investors can participate in the call by dialing 1 (844) 413-3972 and joining the AMS call. A simultaneous webcast will be accessible on the AMS website. A call replay will be available through March 31, 2023, at 1 (877) 344-7529 with access code 7388246. AMS provides technology solutions for radiation therapy and is a leader in Gamma Knife radiosurgery.
American Shared Hospital Services (NYSE American: AMS) announced key management changes effective March 7, 2023. Ray Stachowiak transitions to Executive Chairman after serving as CEO since October 2020. Peter Gaccione, previously COO, is named CEO, bringing over 40 years in medical oncology. AMS has booked its first order of 2023, valued at $1.3 million, which is expected to ship in the second quarter. The company is also searching for a new CFO as Craig Tagawa remains President and CFO until a successor is found. Stachowiak expressed confidence in the new management team's capability to drive AMS forward.
American Shared Hospital Services (AMS) reported a strong third quarter for 2022, with total revenue increasing by 17.8% to $4.83 million. Notably, proton therapy revenue surged by 82% due to higher volumes and average reimbursements. The gross margin expanded to 40.5%, resulting in gross profit of $2 million, a 33.4% increase. Net income rose to $316,000 or $0.05 per share. Adjusted EBITDA also grew by 28% to $1.99 million. As of September 30, 2022, AMS had cash reserves of $11.66 million, indicating robust financial health.
American Shared Hospital Services (NYSE: AMS) will host a quarterly conference call on November 10, 2022, at 3:00 pm ET to discuss its third-quarter financial results. The press release detailing these results will be available before market open on the same day. The call can be accessed by dialing 1 (844) 413-3972 or via a webcast on the company's website. A replay will be available until November 17, 2022. AMS specializes in providing technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment.